Adaptimmune Competitors and Similar CompaniesClear all

Adaptimmune's competitors and similar companies include Bellicum Pharmaceuticals and Metabolon.

	Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.	Bellicum Pharmaceuticals Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.	Metabolon Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.
Founding Date	Founding Date 2008	Founding Date 2004	Founding Date 2000
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare Technology biotech healthtech pharma
Locations	Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB	Locations Houston, US HQ Houston, US Houston, US South San Francisco, US	Locations Morrisville, US HQ Hallbergmoos, DE München, DE
Employees	Employees 4007% decrease	Employees 1386% increase	Employees 1911% increase
Valuation ($)	Valuation ($) 188.5 m	Valuation ($) 778.3 k	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $178m (FY, 2024)	Revenue (est.) $1.5m (FY, 2022)	Revenue (est.) N/A
Net income	Net income ($70.8m) (FY, 2024)	Net income ($25m) (FY, 2022)	Net income N/A
Funding
Total funding raised	Total funding raised $ 107.5m	Total funding raised N/A	Total funding raised $ 95.4m